Metimedi Pharmaceuticals SITEMAP

Pipeline

Our goal is to progress the clinical development of our discoveries,

substantially increase their values, and to ultimately market or out-license.

Pipeline

NASH : Non-alcoholic fatty liver disease, AMD : Age-related macular degeneration, RA : Rheumatoid arthritis,

IBD : inflammatory bowel disease

맨 위로 이동합니다.